Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

SAN FRANCISCO–(BUSINESS WIRE)–Unlearn®, an AI company creating digital twins of clinical trial participants that enable smaller, faster studies, today announced a $50M Series C round led by Altimeter Capital, joined by returning investors Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures, and Necessary Venture Capital. This round of funding was…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks